Ítem
Solo Metadatos
The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá
dc.creator | Van Duin, Mark JM | spa |
dc.creator | Conde, Rafael | spa |
dc.creator | Wijnen, Ben | spa |
dc.creator | Evers, Silvia MAA | spa |
dc.creator | González Rodríguez, Javier Leonardo | spa |
dc.creator | Govers, Mark JG | spa |
dc.creator | Hiligsmann, Mickaël | spa |
dc.date.accessioned | 2020-05-26T00:07:59Z | |
dc.date.available | 2020-05-26T00:07:59Z | |
dc.date.created | 2017 | spa |
dc.description.abstract | Background: This study aimed to assess the impact of comorbidities (CMs) on costs, utilities and health-related quality of life (HRQOL) among HIV patients in Colombia. Methods: A cross-sectional study was conducted among 138 HIV patients at an outpatient clinic in Bogotá to assess their costs, utilities (EQ5D-5L) and HRQOL (EQ-VAS). CMs and other covariates were gathered from patient records. Multiple regression models were conducted to assess the impact of CMs. Results: Of all patients, 72% experienced CMs; of these, half experienced ?2 CMs (N = 49). CMs had a statistically significant impact on utilities when the EQ5D-5L (P = 0.022) was applied among patient with ?2 CMs. No statistical significance was found for the impact of CMs on costs. Conclusion: This study suggests that having multiple CMs significantly influences utility, and CMs have some impact on HRQOL measured using the EQ-VAS but this effect is at the border of significance. No significant impact was observed on costs. © 2016 The Author(s). Published by Informa UK Limited, trading as Taylor and Francis Group. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1080/14737167.2017.1246185 | |
dc.identifier.issn | 14737167 | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/24045 | |
dc.language.iso | eng | spa |
dc.publisher | Taylor and Francis Ltd | spa |
dc.relation.citationEndPage | 310 | |
dc.relation.citationIssue | No. 3 | |
dc.relation.citationStartPage | 303 | |
dc.relation.citationTitle | Expert Review of Pharmacoeconomics and Outcomes Research | |
dc.relation.citationVolume | Vol. 17 | |
dc.relation.ispartof | Expert Review of Pharmacoeconomics and Outcomes Research, ISSN:14737167, Vol.17, No.3 (2017); pp. 303-310 | spa |
dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84992413355&doi=10.1080%2f14737167.2017.1246185&partnerID=40&md5=d93dae38b6561d4e73efb09d0122d839 | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source.instname | instname:Universidad del Rosario | spa |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
dc.subject.keyword | Colombia | spa |
dc.subject.keyword | Comorbidity | spa |
dc.subject.keyword | Cross-sectional study | spa |
dc.subject.keyword | Family | spa |
dc.subject.keyword | Human | spa |
dc.subject.keyword | Human immunodeficiency virus | spa |
dc.subject.keyword | Major clinical study | spa |
dc.subject.keyword | Medical record | spa |
dc.subject.keyword | Model | spa |
dc.subject.keyword | Multiple regression | spa |
dc.subject.keyword | Nonhuman | spa |
dc.subject.keyword | Outpatient department | spa |
dc.subject.keyword | Quality of life | spa |
dc.subject.keyword | Statistical significance | spa |
dc.subject.keyword | Adult | spa |
dc.subject.keyword | Ambulatory care | spa |
dc.subject.keyword | Colombia | spa |
dc.subject.keyword | Comorbidity | spa |
dc.subject.keyword | Economics | spa |
dc.subject.keyword | Female | spa |
dc.subject.keyword | Health care cost | spa |
dc.subject.keyword | HIV Infections | spa |
dc.subject.keyword | Male | spa |
dc.subject.keyword | Middle aged | spa |
dc.subject.keyword | Pathophysiology | spa |
dc.subject.keyword | Regression analysis | spa |
dc.subject.keyword | Adult | spa |
dc.subject.keyword | Ambulatory Care | spa |
dc.subject.keyword | Colombia | spa |
dc.subject.keyword | Comorbidity | spa |
dc.subject.keyword | Cross-Sectional Studies | spa |
dc.subject.keyword | Female | spa |
dc.subject.keyword | Health Care Costs | spa |
dc.subject.keyword | HIV Infections | spa |
dc.subject.keyword | Humans | spa |
dc.subject.keyword | Male | spa |
dc.subject.keyword | Middle Aged | spa |
dc.subject.keyword | Quality of Life | spa |
dc.subject.keyword | Regression Analysis | spa |
dc.subject.keyword | Acquired Immune Deficiency Syndrome (AIDS) | spa |
dc.subject.keyword | Bogotá | spa |
dc.subject.keyword | Burden of disease | spa |
dc.subject.keyword | Colombia | spa |
dc.subject.keyword | Health-related quality of life (HRQOL) | spa |
dc.subject.keyword | Healthcare costs | spa |
dc.subject.keyword | Human Immunodeficiency Virus (HIV) | spa |
dc.subject.keyword | Patient and family costs | spa |
dc.subject.keyword | Utility | spa |
dc.title | The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá | spa |
dc.type | article | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Artículo | spa |